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Synergistic effect of smoking 
on age‑related hearing loss 
in patients with diabetes
Seong Hoon Bae1, Sang Hyun Kwak3, Jae Young Choi1 & Jinsei Jung1,2*
This study investigated the synergistic effects of risk factors on age‑related hearing loss (ARHL) using 
nationwide cross‑sectional data of 33,552 individuals from the 2010‒2013 Korea National Health 
and Nutrition Examination Survey. Patients with ARHL were selected based on their pure‑tone 
audiometry results. Previously reported risk factors for ARHL were analyzed using logistic regression 
and propensity score‑matching, and synergistic effects between risk factors were analyzed using 
propensity score‑matching. Of the 12,570 individuals aged 40–79 years, 2002 (15.9%) met the criteria 
for ARHL. Male sex, exposure to occupational noise, and diabetes showed a significant relationship 
with ARHL (p < 0.05) in both the logistic regression and propensity score‑matching analyses. Smoking 
and diabetes showed the strongest significant synergistic effect on ARHL (odds ratio [OR] 1.963, 95% 
confidence interval [CI] 1.285‒2.998; p = 0.002). In the subgroup analysis based on smoking status, 
current smokers with diabetes had a significant relationship with ARHL (OR 1.883, CI 1.191‒2.975; 
p = 0.009), whereas ex‑smokers with diabetes did not (OR 1.250; CI 0.880‒1.775; p = 0.246). This 
implies that current smokers with diabetes may benefit from the cessation of smoking. In conclusion, 
patients with diabetes should strictly avoid or cease smoking to prevent the progression of ARHL.
Age-related hearing loss (ARHL) is the most common cause of sensory hearing impairment in older adults. 
It affects tens of millions of people worldwide, and an estimated one-third of people over the age of 65 years 
currently have hearing  loss1,2. Several recent studies have suggested an association between hearing loss and 
age-related diseases, such as cognitive impairment, depression, increased risk of falling, etc.3, which raises the 
importance of hearing loss as a public health problem. Furthermore, the number of patients with ARHL contin-
ues to increase markedly. In 2020, an estimated 56% of individuals aged 70 years or older have ARHL, and this 
percentage is expected to increase to 67% by  20601. Symptoms of ARHL develop at approximately 50 years of 
age and gradually worsen, without recovery.
Several previous cohort and cross-sectional studies have suggested risk factors for ARHL that have been 
categorized as genetic, environmental, and  medical4. Genetic risk factors include sex and genetic mutations. A 
previous prospective study has shown that men are at a higher risk of developing ARHL than  women5. Addition-
ally, several reports have elucidated the association between genetic mutations and ARHL, although these cannot 
adequately explain the high incidence of ARHL. Occupational noise exposure is an environmental risk factor, 
and susceptibility to noise can differ among individuals. The association between noise exposure and ARHL is 
generally accepted, and the use of ear protection devices in noisy environments is  recommended6,7. Smoking 
has also been suggested to be an environmental risk factor for  ARHL4,8. Furthermore, various medical risk fac-
tors have been studied and suggested, such as  stroke9, cardiovascular disease (CVD)9,10, hypertension (HTN)11, 
diabetes  mellitus12,  obesity13, and  dyslipidemia14,15. However, the effects of some of these proposed risk factors 
remain controversial, perhaps due to the complex etiologies of ARHL and the small sample sizes of previous 
 studies16,17. Furthermore, the synergistic effects of these risk factors have not been studied in-depth, which may 
be crucial in explaining the pathophysiology of ARHL in humans.
This study utilized the data of 33,552 individuals included in the nationwide annual report of the 2010‒2013 
Korea National Health and Nutrition Examination Survey (KNHANES)18 to identify the synergistic interrelation-
ship between the risk factors for ARHL. Using this population-based cross-sectional data, we analyzed the odds 
ratio (OR) for each combination of modifiable risk factors for ARHL, in order to substantiate the deleterious 
combinatorial effects of these risk factors. The propensity score-matching (PSM) model was preferably chosen 
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for this analysis, as it substantially minimizes the collinearity of variables, which might be underestimated in the 
logistic regression model, and can be ideally applied to measure the accurately quantified OR of the combined 
risk factors for ARHL.
Results
Demographic information and evaluation of risk factors. The KNHANES is an annual nationwide 
population-based cross-sectional health examination and survey. In the 2010‒2013 survey, 33,552 individuals 
were investigated without a serial follow-up. Among them, a total of 12,570 individuals were included in this 
study; of these, 2002 (15.9%) individuals met the criteria for inclusion in the ARHL group. The mean participant 
age was 57.21 ± 10.86 years, and 43.6% of the participants were males.
Ten candidate variables that have previously been suggested as risk factors for ARHL were investigated 
(Supplementary Table S1 online). Environmental risk factors such as smoking history and occupational noise 
exposure history were investigated; 2296 (18.3%) individuals were current smokers, and 1755 (14.0%) individu-
als had experienced occupational noise exposure for > 3 months. Medical risk factors such as HTN, diabetes, 
dyslipidemia, stroke, CVD, and obesity were also investigated.
Common risk factors for ARHL in logistic regression and propensity score‑matching. We 
included the 10 proposed risk factors as independent variables and ARHL as a dependent variable in the regres-
sion model. The six variables (age, occupational noise exposure, stroke, male sex, current smoking, and dyslipi-
demia) included in the final regression model showed 84.8% accuracy of classification and a Nagelkerke’s  R2 of 
0.306 (i.e., 30.6% of events could be explained by this model) (Table 1). The p value, according to the Hosmer‒
Lemeshow test, was 0.596, which indicated that this regression model was valid. In the regression model, occu-
pational noise exposure showed the highest correlation with ARHL. The well-known cumulative effect of age 
on noise-induced hearing loss was consistent with this  result19. Among the included risk factors, noise exposure 
(Exp [B] 1.722, CI 1.485‒1.998), male sex (Exp [B] 1.419, CI 1.262‒1.595), current smoking (Exp [B] 1.231, 
CI 1.057‒1.434), and diabetes (Exp [B] 1.168, CI 1.009‒1.351) showed a significant positive correlation with 
ARHL. Additionally, dyslipidemia (Exp [B] 0.808, CI 0.701‒0.931) showed a significant negative correlation 
with ARHL, although this result should be interpreted while taking the vascular pathology of dyslipidemia and 
its relationship with other diseases into consideration.
In the PSM analysis, male sex, HTN, diabetes mellitus, and noise exposure showed significantly increased 
ORs (Table 2). Among these, noise exposure history had the highest OR (OR 1.779, CI 1.461‒2.167), which 
was consistent with the results of the logistic regression analysis. HTN (OR 1.157, CI 1.004‒1.333) showed a 
significantly increased OR in the PSM but not in the logistic regression analysis. The ARHL risk factors common 
to both statistic models were male sex, noise exposure, and diabetes.
Table 1.  Risk factors for age-related hearing loss in the logistic regression analysis model. Accuracy of 
classification: 84.8%, Nagelkerke’s  R2: 0.306, Hosmer‒Lemeshow test (p value): 0.596. CI, confidence interval.
Significant variables Exp (B) 95% CI P value
Age 1.139 1.132–1.146  < 0.001
Occupational noise exposure 1.722 1.485–1.998  < 0.001
Male sex 1.419 1.262–1.595  < 0.001
Dyslipidemia 0.808 0.701–0.931 0.003
Current smoker 1.231 1.057–1.434 0.007
Diabetes 1.168 1.009–1.351 0.038
Table 2.  Odds ratios of age-related hearing loss for each risk factor in the propensity-score-matched groups. 
CVD cardiovascular disease; CI confidence interval; HTN hypertension; OR odds ratio.
Risk factor* Pairs OR 95% CI p-value
Current smoke 1945 1.171 0.979–1.401 0.091
Diabetes* 1129 1.285 1.058–1.562 0.013
Dyslipidemia 1598 0.902 0.752–1.082 0.286
HTN* 2407 1.157 1.004–1.333 0.047
Stroke 242 1.080 0.735–1.588 0.768
CVD 107 0.709 0.382–1.314 0.348
Sex* 3178 1.434 1.252–1.642  < 0.001
Obese 3634 1.064 0.932–1.216 0.377
Noise* 1595 1.779 1.461–2.167  < 0.001
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Synergistic effects of risk factors on ARHL. Next, we investigated the synergistic effects of the modifia-
ble risk factors. Modifiable risk factors were defined as chronic diseases of lifestyle (HTN, diabetes, dyslipidemia, 
and obesity) and current smoking. Individuals who had both these targeted risk factors were compared to those 
who had a single or no targeted risk factor. Ten combinations of the five modifiable risk factors were investigated 
by PSM (Table  3). Notably, the combination of diabetes and current smoking was associated with the most 
significant increase in the prevalence of ARHL (OR 1.963, 95% CI 1.285–2.998; p = 0.002), after completely 
controlling for the other risk factors. The combination of diabetes and HTN was also statistically significant, but 
the OR (OR 1.388, 95% CI 1.100 − 1.750; p = 0.007) was smaller than that for the combination of diabetes and 
smoking. Other combinations showed no significant difference in terms of the prevalence of ARHL according 
to the presence of risk factors.
Next, we performed a subgroup analysis of the prevalence of ARHL according to smoking status. The OR 
of ARHL did not differ between the ex-smokers and the never-smoked group (OR 1.008, 95% CI 0.789–1.287; 
p = 1.000) (Supplementary Table S2 online). Additionally, there was no synergistic effect between ex-smoking 
status and diabetes in terms of the OR of ARHL (OR 1.250; 95% CI, 0.880–1.775, p = 0.246) (Table 4). However, 
in the analysis of the current smokers and the never-smoked subgroups, a synergistic effect on the odds of 
developing ARHL was observed between current smoking status and diabetes (OR 1.883, 95% CI 1.191‒2.975; 
p = 0.009) (Table 4). The combined effect of current smoking status and diabetes on the hearing function is clearly 
presented in Fig. 1. Unlike current smoking status, the ex-smoking status did not increase the OR of ARHL in 
patients with diabetes.
Discussion
In this study, we performed a PSM analysis and observed that the combination of smoking history and diabetes 
contributed most significantly to ARHL. Moreover, we observed that diabetic ex-smokers showed a reduced OR 
compared to current diabetic smokers. In the PSM analysis, the OR of the combination of diabetes and current 
smoking (1.963) was higher than the ORs of current smoking (1.171), diabetes (1.285), and HTN (1.157) alone as 
well as the combination of diabetes and HTN (1.388).Considering that both diabetes and smoking may affect 
cardiovascular circulation, the progression of ARHL may be attributed to previously suggested risk factors, such 
as HTN, dyslipidemia, stroke, obesity, and  CVD9,14,20.
ARHL is a slowly progressive disease that develops over decades and has an extremely complex etiology. 
Although a definite causative gene contributing to the development of ARHL in the population is unknown, 
numerous genes with common polymorphisms or rare variants have been suggested as a cause for ARHL in some 
patients; for instance, KCNQ4 is a candidate gene associated with hearing loss that progresses with  age16,21–29. 
However, the genetic information of the subjects was not available in this study. The analysis of genetic polymor-
phisms associated with ARHL would be more helpful in substantiating the causative relations of the risk factors 
for ARHL in the future. Further, several environmental contributors to ARHL have been suggested, including 
Table 3.  Odds ratios of age-related hearing loss for each combination of two risk factors in the propensity 
score-matched groups. *Compared to the group with one or no risk factors; CI confidence interval; HTN 
hypertension; OR odds ratio; #p value < 0.05.
Risk factor* Pairs OR 95% CI P value
Diabetes + HTN# 723 1.388 1.100 –1.750 0.007
Diabetes + dyslipidemia 472 1.012 0.745–1.375 1.000
Diabetes + obesity 550 1.088 0.818–1.446 0.612
Diabetes + current  smoker# 265 1.963 1.285–2.998 0.002
HTN + dyslipidemia 1042 0.977 0.791–1.207 0.871
HTN + current smoker 470 1.217 0.895–1.656 0.240
HTN + obesity 1571 1.105 0.931–1.311 0.274
Dyslipidemia + current smoker 241 1.029 0.644–1.644 1.000
Dyslipidemia + obesity 793 0.934 0.723–1.207 0.648
Current smoking + obesity 705 1.271 0.904–1.786 0.195
Table 4.  Subgroup analyses of odds ratios of age-related hearing loss according to smoking status in the 
propensity-score-matched groups. *Compared to the group with one or no risk factors; CI confidence interval; 
OR odds ratio; #p value < 0.05b.
Subgroup Risk factor Pairs OR 95% CI p value
Ex- and never-smoker
Ex-smoking 962 1.008 0.789 –1.287 1.000
Ex-smoking + diabetes* 326 1.250 0.880–1.775 0.246
Current and never-smoker
Current smoking 950 1.216 0.941–1.572 0.151
Current smoking + diabetes*# 230 1.883 1.191–2.975 0.009
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ototoxic medication, alcohol intake, tobacco use, and head  trauma17. Because ARHL has complex etiologies, the 
effects of some risk factors, such as diabetes and dyslipidemia, remain  controversial4,14,30. In this study, dyslipi-
demia showed a negative correlation and no correlation with ARHL in the logistic regression and PSM analysis, 
respectively. Interestingly, dyslipidemia seems to have a lower association with ARHL, speculation of which has 
been supported by recent  studies31,32. We also observed a discrepancy in the effects of some risk factors (HTN, 
smoking) on ARHL between logistic regression and PSM analyses. Additionally, other medical conditions, such 
as CVD, stroke, obesity, and dyslipidemia, did not contribute to the difference in the OR for ARHL in logistic 
regression and PSM analyses, which was inconsistent with the findings of previous  literature9–12. This may indicate 
that several medical conditions have mutual effects, and no single effect from each risk factor can explain the 
pathology of ARHL. In this regard, we consider that multifactorial analyses may be more helpful in explaining 
the pathophysiology of ARHL. Considering that several risk factors, such as HTN, diabetes, CVD, dyslipidemia, 
obesity, and smoking, are associated with vascular disease and are interrelated, controlling for confounding fac-
tors is important when evaluating a single risk factor for  ARHL9,14,20.
Meanwhile, the logistic regression analysis revealed that older age, noise exposure, male sex, current smoking, 
and diabetes were significantly associated with ARHL, whereas the PSM revealed that noise exposure, male sex, 
diabetes, and HTN significantly increase the OR of ARHL. Because the PSM and logistic regression analyses 
are complementary, it is reasonable to adopt the results from both methods. In particular, we used PSM analysis 
to confirm the hierarchical association of the known risk factors for ARHL without the interactions between 
covariates. PSM analysis was also preferably chosen for determining the synergistic effects of each risk factor, 
since PSM can substantially minimize the collinearity of variables, thereby accurately predicting the synergistic 
effects. Additionally, PSM can convincingly define an association hierarchy among varying combinations by 
perfectly matching the other co-variables between groups. Although the interaction regression model using the 
cross-product variable can be applied to evaluate the interactions of covariates, it is less appropriate in this study 
because too many medical conditions should be hypothesized as interacting conditions.
Smoking is a modifiable risk factor in preventing the progression of ARHL in patients with diabetes. In 
particular, we observed that ex-smoking status did not have a significant effect on the OR for ARHL in diabetic 
patients, indicating that ARHL may be alleviated if a patient quit smoking. The synergistic mechanism of smok-
ing and diabetes in ARHL remains unclear, and the duration of smoking cessation that is required to obtain a 
reduced OR of ARHL is not known. In general, smoking and diabetes have synergistic harmful effects on blood 
circulation; smoking increases the progression of nephropathy and the risk of CVD in patients with  diabetes33–35. 
It has also been reported that C-reactive protein, a systemic inflammation marker, is increased in current smok-
ers compared to ex-smokers and those who have never  smoked36,37. Moreover, a recent study has suggested that 
inflammatory food consumption is closely related to the incidence of  ARHL38. Given that chronic inflammation 
increases the risk of cardiovascular events, as supported by the results of the JUPITER trial, smoking and diabetes 
may cause vascular pathologies, such as  atherosclerosis39. This synergism may eventually destroy the vascular 
supply to the auditory end organ, the cochlea, and cause progressive hearing deterioration. Another possible 
mechanism may be direct cellular damage to the sensory hair cells in the cochlea or auditory neural pathway. In 
a mouse model, a high glucose level affects auditory midbrain function, loss of spiral ganglion cells, decreased 
cochlear blood flow, and increased susceptibility to noise  exposure40,41. Smoking also increases susceptibility 
to noise exposure and decreases spiral ganglion cells due to increased oxidative stress in the mouse  model42,43. 
According to the data in our study, cochlear damage due to chronic smoking may be reversed through cessation 
of smoking. Therefore, strict and timely control of smoking is advised, particularly in patients with diabetes.
A limitation of this study is that it did not provide specific information on the duration of smoking cessation 
required to observe its preventive effect on ARHL in diabetic patients. Prospective observational studies may be 
Figure 1.  Pure-tone audiograms of propensity score-matched individuals in the analysis of the current smokers 
and never-smoked subgroups. Among 12,570 enrolled patients, 2296 current smokers and 7414 never-smoked 
individuals were included in the subgroup analysis. Propensity score-matching (PSM) was performed for age, 
male sex, hypertension, dyslipidemia, stroke, cardiovascular diseases, occupational noise exposure, and obesity 
as risk factors. In the propensity score-matched subjects, pure-tone thresholds were compared according to (a) 
the presence of diabetes (PSM pairs = 794), (b) current smoking status (PSM pairs = 950; denoted as c-Smoker in 
the figure), and (c) the combination of diabetes and current smoking status (PSM pairs = 230). c-Smoker, current 
smoker; * p < 0.05, ** p < 0.005, *** p < 0.001; paired t-test. The error bar indicates standard deviation.
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needed to clarify details about the prevention of ARHL. Further, the PSM analysis has an innate limitation; in 
an ideal PSM, it is hypothesized that all possible covariates are included. In this study, 10 validated risk factors 
from previously published studies were included. However, there may be additional latent covariates affecting 
the development of ARHL (i.e., genetic polymorphisms) that were not considered in our analyses. Future studies 
should reflect novel discovered risk factors for ARHL. Additionally, the causal relationship between ARHL and 
several risk factors could not be clearly elucidated in this study. This is because the KNHANES is a cross-sectional 
survey, which may have led to a reverse causality bias in this study. However, considering the pathophysiologic 
mechanism of the medical risk factors associated with ARHL, it is unlikely that ARHL may have increased the 
risk of medical diseases such as HTN, diabetes, and dyslipidemia. Further, the reduced OR in diabetic ex-smokers 
compared to current diabetic smokers seems to imply that the cessation of smoking can ameliorate the risk of 
ARHL; however, this result should not be overestimated since a cross-sectional study cannot fully elucidate the 
direction of causality. Therefore, further prospective studies may be required in the future to verify the amelio-
rating effects of smoking cessation. Lastly, the World Health Organization recently defined ARHL as a hearing 
threshold of > 40 dB HL in 0.5, 1, 2, and 4 kHz frequencies. Although the cut-off threshold of 30 dB HL used in 
this study has been applied in several publications, the results, especially the OR values, may slightly vary if the 
cut-off threshold is set at 40 dB HL.
In conclusion, several environmental and medical factors may affect the risk of ARHL. Among them, noise 
exposure, male sex, and diabetes seem to be important factors, based on both the logistic regression and PSM 
analyses. In addition to the individual effect of each risk factor, a combinatorial effect of these factors should be 
considered when attempting to prevent ARHL. As the most modifiable factor, cessation of smoking should be 
strongly prescribed in high-risk subjects, such as diabetic patients.
Methods
Participants. A total of 12,570 individuals (all Korean) included in the 2010 − 2013  KNHANES18 partici-
pated in this study. The inclusion criteria were normal findings on otoscopic examination, presence of pure-tone 
audiometry data, and an age of 40–79 years. We excluded individuals who showed a difference of > 30 dB HL 
in the bilateral pure-tone threshold since ARHL is typically associated with symmetric hearing  impairment4,44. 
Individuals with missing values regarding any candidate risk factor [age, sex, HTN, diabetes, dyslipidemia, 
stroke, CVD, occupational noise exposure, smoking history, and body mass index (BMI)] were also excluded 
(see Supplementary Figure S1 online).
All study participants included in the 2010 − 2013 KNHANES agreed to participate in the survey and informed 
consent was obtained for all participants or their legal guardians. The 2010 − 2013 KNHANES was approved by 
the Institutional Review Board of the Korea Centers for Disease Control (IRB of KCDC). The approval number 
for the 2010 survey is 2010–02CON-21-C, for the 2011 survey is 2011-02CON-06-C, for the 2012 survey is 
2012-01EXP-01-2C, and for the 2013 survey is 2013-07CON-03-4C. KNHANES was performed in accordance 
with relevant guidelines and regulations provided by the IRB of KCDC.
Korea National Health and Nutrition Examination Survey. The KNHANES is a cross-sectional sur-
vey that has been conducted annually in South Korea since 1998. The fifth KNHANES was conducted from 
2010 to 2012, and the sixth KNHANES was conducted from 2013 to 2015. The sample design of the KNHANES 
was extracted using a two-stage stratified cluster (region and household) sampling. The rate of participation 
in the fifth and sixth KNHANES was 80.8% and 78.3%, involving 25,533 and 22,948 people, respectively. The 
KNHANES consisted of three categories: the medical survey, the nutrition survey, and the health examina-
tion. Specifically, we only collected datasets that included both noise exposure history and a pure-tone audio-
gram. Although pure-tone audiometry was conducted from 2008 to 2013, the data from the fourth KNHANES 
(2007–2009) was not included in this study as it did not include a noise exposure history survey. Since noise 
exposure history-taking and the pure-tone audiometry test were conducted only from 2010 to 2013, the data 
from the fifth KNHANES (2010–2012) and the sixth KNHANES (for 2013) were merged vertically to increase 
the statistical validity. Medical history and smoking information were obtained from the medical survey. BMI 
and air-conduction pure-tone threshold data were obtained from the health examination.
Hearing assessment. The subjects underwent pure-tone audiometry in an ordinary soundproof booth 
that was installed in the vehicle. The test included pure-tone air-conduction threshold measurements at 0.5, 1, 
2, 3, 4, and 6 kHz. Individuals with an average pure-tone threshold of ≥ 30 dB HL in the “better” ear at 0.5, 1, 2, 
and 3 kHz (according to the guidelines of the American Academy of Otolaryngology-Head and Neck surgery 
 foundation45) were included in the ARHL  group46,47. An otorhinolaryngologist examined and reported the tym-
panic membrane findings in each subject. A well-visualized tympanic membrane without pathologic findings 
such as retraction, perforation, or middle ear effusion and no cerumen impaction in the middle ear and external 
auditory canal were defined as normal findings.
Risk factors. We selected 10 candidate risk factors: age, male sex, HTN, diabetes, dyslipidemia, stroke, CVD, 
occupational noise exposure, smoking, and obesity. Physician-diagnosed diseases (HTN, diabetes, dyslipidemia, 
stroke, and CVD) were identified through a self-reported survey. Smoking history was categorized into three 
groups: never-smoked, ex-smoker, and current smoker. The ex-smoker category indicated that a subject had 
smoked daily during their lifetime but was not smoking at the time of the survey. BMI was converted into a 
dichotomous variable termed “obesity”; a BMI > 25 kg/m2 was considered  obese48. Occupational noise exposure 
history was recorded via a survey question asking if participants had worked in a noisy environment (difficulty 
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in communication with moderate loudness [55 dB HL] between workers) for > 3 months. Information on age 
and sex was obtained from residence registration data.
Statistical analysis. The 10 candidate risk factors were treated as interacting covariates, and logistic regres-
sion and PSM analyses were performed with the same sample and covariates. In order to classify the most associ-
ated determinants, the logistic regression analysis was performed using the stepwise backward selection (cut-off 
p value = 0.05) method with the Hosmer‒Lemeshow test (valid if p value > 0.05). The accuracy of classification 
and Nagelkerke’s  R2 were calculated to evaluate the explanatory power. ARHL was included as a dependent vari-
able, and the 10 risk factors were included as independent variables in the regression model.
Propensity scores were calculated using logistic regression analysis, which included the target risk factor 
as a dependent variable and other risk factors as independent variables. We performed 1:1 matching between 
individuals with the same propensity score to obtain two exact propensity score-matched groups. From the 
matched pairs, ORs and 95% confidence intervals (CIs) were calculated from a 2 × 2 table, including ARHL 
(presence or absence) and the target risk factor (presence or absence). We defined two groups to evaluate the 
ORs of the combined risk factors: one was the combined risk group with both risk factors, and the other was a 
control group with one or no risk factors. After classification, PSM and OR calculation was performed in the 
aforementioned manner.
The McNemar’s test was performed to evaluate the statistical significance of the difference in ARHL risk 
factors between the propensity score-matched groups. The pure-tone threshold of each frequency was com-
pared using two-way analysis of variance with Sidak’s post-hoc. A p value < 0.05 was considered statistically 
significant. The statistical analyses were conducted using Statistical Package for the Social Sciences version 25.0 
(IBM; Armonk, NY).
Data availability
The data are available from the corresponding author upon reasonable request.
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